DEST — Destiny Pharma Balance Sheet
0.000.00%
Last trade - 00:00- £8.38m
- £2.00m
Annual balance sheet for Destiny Pharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 7.48 | 9.74 | 4.65 | 4.9 | 6.38 |
| Net Total Receivables | 0.911 | 1.17 | 0.992 | 1.41 | 0.9 |
| Prepaid Expenses | |||||
| Total Current Assets | 8.52 | 11.4 | 5.99 | 6.51 | 7.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.033 | 0.018 | 0.036 | 0.025 | 0.019 |
| Net Intangible Assets | |||||
| Total Assets | 8.56 | 13.7 | 8.28 | 8.8 | 9.96 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 0.798 | 1.27 | 0.773 | 1.17 | 0.768 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.798 | 1.27 | 0.773 | 1.17 | 0.768 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 7.76 | 12.4 | 7.51 | 7.63 | 9.19 |
| Total Liabilities & Shareholders' Equity | 8.56 | 13.7 | 8.28 | 8.8 | 9.96 |
| Total Common Shares Outstanding |